Editorial: Influenza: A recurrent challenge to transplantation

Transplant Infectious Disease

Volumn 12, Issue 2, 2010, Pages 95-97

  Ison, M G ^a   Hirsch, H H ^b,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; INFLUENZA VACCINE; OSELTAMIVIR; PERAMIVIR; ZANAMIVIR;

DISEASE TRANSMISSION; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; GRAFT RECIPIENT; HUMAN; IMMUNOASSAY; IMMUNOCOMPROMISED PATIENT; INFECTION PREVENTION; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; NONHUMAN; ORGAN TRANSPLANTATION; PANDEMIC INFLUENZA; PRIORITY JOURNAL; RECURRENT INFECTION; RHINOVIRUS; RISK ASSESSMENT; RISK REDUCTION; SEASONAL VARIATION; STEM CELL TRANSPLANTATION; TREATMENT DURATION; VIRAL RESPIRATORY TRACT INFECTION; VIRUS REPLICATION; VIRUS SHEDDING; VIRUS STRAIN; DRUG ADMINISTRATION; INFLUENZA; NOTE; POSTOPERATIVE COMPLICATION; VACCINATION;

ANTIVIRAL AGENTS; DRUG ADMINISTRATION SCHEDULE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; ORGAN TRANSPLANTATION; OSELTAMIVIR; POSTOPERATIVE COMPLICATIONS; VACCINATION;

EID: 77950586322     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2010.00501.x     Document Type: Editorial

References (15)

1. Monto AS. Epidemiology of influenza. Vaccine 2008 26 (Suppl 4) : D45 D48.
2. Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 2009 459 (7249) : 931 939.
3. Casper C, Englund J, Boeckh M. How we treat influenza in patients with hematologic malignancies. Blood 2009 [Epub ahead of print].
4. Ison MG. Respiratory viral infections in transplant recipients. Antivir Ther 2007 12 (4 Part B) : 627 638. (Pubitemid 47235505)
5. Boeckh M. The challenge of respiratory virus infections in hematopoietic cell transplant recipients. Br J Haematol 2008 143 (4) : 455 467.
6. Dumoulin A, Widmer AF, Hirsch HH. Comprehensive diagnostics for respiratory virus infections after transplantation or after potential exposure to swine flu AH1N1: what else is out there? Transpl Infect Dis 2009 11 (4) : 287 289.
7. Khanna N, Steffen I, Studt JD, et al. Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2009 11 (2) : 100 105.
8. Peck AJ, Englund JA, Kuypers J, et al. Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection. Blood 2007 110 (5) : 1681 1688. (Pubitemid 47443987)
9. Birdwell KA, Ikizler MR, Sannella EC, et al. Decreased antibody response to influenza vaccination in kidney transplant recipients: a prospective cohort study. Am J Kidney Dis 2009 54 (1) : 112 121.
10. Lattes R, Jacob N, de la Fuente J, Fragle G, Massari P. Pandemic influenza AH1N1 and organ donation. Transpl Infect Dis 2010 12 (2) : 169 172.
11. Meylan PR, Aubert JD, Kaiser L. Influenza transmission to recipient through lung transplantation. Transpl Infect Dis 2007 9 (1) : 55 57. (Pubitemid 46257201)
12. Kumar D, Morris MI, Kotton CN, et al. Guidance on novel influenza AH1N1 in solid organ transplant recipients. Am J Transplant 2010 10 (1) : 18 25.
13. Watcharananan SP, Suwatanapongched T, Watcharawanichkul P, Chantratitaya W, Mavichak V, Mossad SB. Influenza AH1N1 2009 pneumonia in kidney transplant recipients: characteristics and outcomes following high-dose oseltamivir exposure. Transpl Infect Dis 2010 12 (2) : 127 131.
14. Treanor JJ, Hayden FG, Vrooman PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA 2000 283 (8) : 1016 1024.
15. Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) Virus-United States, 2009. Morb Mortal Wkly Rep 2009 58 (30) : 826 829.